Bruce Arnow, Ph.D.

Clinical Focus

• Depression, Unipolar
• Psychology
• Evidence-Based Psychotherapy

Administrative Appointments

• Director, Behavioral Medicine Clinic, Department of Psychiatry and Behavioral Sciences (1985 - present)
• Chief, Adult Outpatient Clinics, Department of Psychiatry and Behavioral Sciences (2000 - 2006)
• Chief, Psychology Service, Department of Psychiatry and Behavioral Sciences (1992 - present)
• Director of Psychology Training, Department of Psychiatry and Behavioral Sciences (1992 - present)
• Co-Director of Clinical Training, PGSP/Stanford Psy.D. Consortium, Department of Psychiatry and Behavioral Sciences (2006 - present)
View All 6administrative appointments of Bruce Arnow

Professional Education

Postdoctoral Advisees

Jennifer McCollum, Shokooh Miry, Jasmine Teleki, Allison Thompson, Sanno Zack

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Research Interests

Current research interests include treatment outcome for major depression, particularly chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization; and the relationship between brain activation and sexual response in men and women.

Clinical Trials

• A safety and efficacy trial of flibanserin in premenopausal women with HSDD No longer recruiting

Publications

• Depression. In D McKay, JS Abramowitz, S Taylor (Eds.) Arnow BA, Post LI. Cognitive-Behavioral Therapy for refractory cases: Turning failure into success. Washington, DC: American Psychological Association Press.. 2009: 183-210
• Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Denton WH, Carmody TJ, Rush AJ, Thase ME, Trivedi MH, Arnow BA, Klein DN, Keller MB. Psychol Med. 2009: 1-10
• Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Klein DN, Arnow BA, Barkin JL, Dowling F, Kocsis JH, Leon AC, Manber R, Rothbaum BO, Trivedi MH, Wisniewski SR. Depress Anxiety. 2009; 26 (8): 701-10
• Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, Manber R, Blalock JA, Keitner GI, Thase ME. J Affect Disord. 2009; 117 (3): 174-9
• Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. Kocsis JH, Leon AC, Markowitz JC, Manber R, Arnow B, Klein DN, Thase ME. J Clin Psychiatry. 2009; 70 (3): 354-61